.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Colorcon
Novartis
McKinsey
Fuji
Teva
Queensland Health
Healthtrust
Daiichi Sankyo
Dow

Generated: November 23, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: avibactam sodium; ceftazidime

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Cerexa
AVYCAZ
avibactam sodium; ceftazidime
POWDER;IV (INFUSION)206494NDAAllergan, Inc.0456-2700-1010 VIAL, SINGLE-USE in 1 CARTON (0456-2700-10) > 1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE (0456-2700-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson
Cantor Fitzgerald
Citi
QuintilesIMS
Moodys
Daiichi Sankyo
Harvard Business School
Boehringer Ingelheim
Fuji

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot